Clinical outcomes of gastric cancer surgery after liver transplantation

• Published in: Annals of surgical treatment and research 2023-02, Vol.104 (2), p.101-108
• Main Authors: Kim, Sunjoo, Lee, Hyuk-Joon, Alzahrani, Fadhel, Kim, Jeesun, Kim, Sa-Hong, Kim, Sara, Cho, Yo-Seok, Park, Ji-Hyeon, Lee, Jeong-Moo, Kong, Seong-Ho, Park, Do Joong, Suh, Kyung-Suk, Yang, Han-Kwang
• Format: Article
• Language: English
• Subjects: Original
• ISSN: 2288-6575; 2288-6796
• DOI: 10.4174/astr.2023.104.2.101

malignancy is common after liver transplantation (LT); however, there are limited reports on the clinical outcomes of gastric cancer surgery after LT. Our study aimed to investigate the feasibility and safety of gastric cancer surgery after LT. Seventeen patients underwent gastric cancer surgery after LT at a single institution between January 2013 and June 2021. We retrospectively collected data on surgical complications, survival, and recurrence status of these cases. Fifteen patients (88.2%) underwent curative gastrectomy, with 10 open distal (66.7%) and 5 laparoscopic distal (33.3%) gastrectomies. Surgical and severe complication rates were 3 of 15 (20.0%) and 1 of 15 (6.7%), respectively. There were no significant differences between laparoscopic (33.3%) and open surgery (66.7%) in terms of operation time and complication rate. No surgery-related mortalities occurred. Immunosuppressants could be maintained without difficulty, and no suspicious acute rejection was identified during the perioperative period. There was 1 recurrence after curative surgery (recurrence rate, 6.7%), and the 5-year cancer-specific survival rate after curative surgery was 93.3%. Laparoscopic gastrectomy can be safely done even after LT in terms of postoperative complications and graft safety.